Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
- PMID: 21387374
- PMCID: PMC3084507
- DOI: 10.1002/ana.22366
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Abstract
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use.
Copyright © 2011 American Neurological Association.
Comment in
-
Diagnostic criteria in multiple sclerosis: headed in the right direction but still a ways to go.Ann Neurol. 2011 Feb;69(2):234-6. doi: 10.1002/ana.22388. Ann Neurol. 2011. PMID: 21387367 No abstract available.
-
Multiple sclerosis II: new diagnostic criteria, association with smoking and effects of cannabis on cognitive function.J Neurol. 2011 May;258(5):954-7. doi: 10.1007/s00415-011-6049-2. J Neurol. 2011. PMID: 21512740 No abstract available.
-
2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging.Ann Neurol. 2011 Jul;70(1):182-3. doi: 10.1002/ana.22490. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710623 No abstract available.
-
Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.Ann Neurol. 2011 Sep;70(3):520; author reply 521. doi: 10.1002/ana.22508. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710627 No abstract available.
-
Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria.Ann Neurol. 2011 Jul;70(1):183; author reply 183-4. doi: 10.1002/ana.22466. Ann Neurol. 2011. PMID: 21786311 No abstract available.
Similar articles
-
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703. Ann Neurol. 2005. PMID: 16283615 Review.
-
[Diagnosis of multiple sclerosis: A review of the 2017 revisions of the McDonald criteria].Ideggyogy Sz. 2018 Sep 30;71(9-10):321-329. doi: 10.18071/isz.71.0321. Ideggyogy Sz. 2018. PMID: 30335264 Review. Hungarian.
-
[Diagnosis of multiple sclerosis--the 2010 revision of the McDonald criteria].Ugeskr Laeger. 2012 Mar 26;174(13):862-5. Ugeskr Laeger. 2012. PMID: 22456173 Danish.
-
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change.Curr Opin Neurol. 2019 Jun;32(3):327-337. doi: 10.1097/WCO.0000000000000699. Curr Opin Neurol. 2019. PMID: 30985371 Review.
-
Revised diagnostic criteria of multiple sclerosis.Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12. Autoimmun Rev. 2014. PMID: 24424194 Review.
Cited by
-
Abnormal Vestibulo-Ocular Reflex Function Correlates with Balance and Gait Impairment in People with Multiple Sclerosis.Audiol Res. 2024 Sep 9;14(5):799-808. doi: 10.3390/audiolres14050067. Audiol Res. 2024. PMID: 39311220 Free PMC article.
-
Diet-Induced Changes in Functional Disability among People with Multiple Sclerosis: A Secondary Pooled Analysis of Two Randomized Controlled Pilot Trials.Sclerosis. 2024 Sep;2(3):156-165. doi: 10.3390/sclerosis2030011. Epub 2024 Jul 4. Sclerosis. 2024. PMID: 39296470 Free PMC article.
-
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.J Cent Nerv Syst Dis. 2024 Sep 13;16:11795735241260563. doi: 10.1177/11795735241260563. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 39290861 Free PMC article.
-
Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort.Neurol Sci. 2024 Sep 17. doi: 10.1007/s10072-024-07767-3. Online ahead of print. Neurol Sci. 2024. PMID: 39285108
-
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414. BMJ Open. 2024. PMID: 39284697 Free PMC article. Clinical Trial.
References
-
- Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568. - PubMed
-
- Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;1:227–231. - PubMed
-
- Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988;38:180–185. - PubMed
-
- Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997;120:2059–2069. - PubMed
-
- Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822–1825. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical